Author | Erin Johanek, PharmD


High Hopes for Inclisiran. Will the Third Time be the Charm for PCSK9 Inhibition?

June 22, 2020

The two PCSK9 inhibitors have fallen far short of expectations. Inclisiran, which works by RNA inference, only needs to be injected twice a year. 

Rheumatoid Arthritis Drug Pipeline at a Trickle

March 05, 2020

DMARDs and the JAK Inhibitors have improved RA treatment. But not many new drugs are in the offing at the moment.

NASH Drug Pipeline Shows Promise

February 05, 2020

The first FDA-approved product for NASH on the horizon.

Will new autoimmune drugs address cost concerns?

December 27, 2016

Find out what’s in the drug pipeline for autoimmune disease.